MED MEDIFAST INC

NYSE medifastinc.com


$ 13.26 $ -0.05 (-0.38 %)    

Tuesday, 14-Oct-2025 13:34:23 EDT
QQQ $ 601.14 $ 5.92 (0.99 %)
DIA $ 464.19 $ 7.18 (1.57 %)
SPY $ 664.46 $ 7.16 (1.09 %)
TLT $ 90.66 $ 0.03 (0.03 %)
GLD $ 381.95 $ 3.76 (0.99 %)
$ 13.26
$ 13.17
$ 13.24 x 6
$ 13.27 x 24
$ 13.14 - $ 13.16
$ 11.57 - $ 21.98
150,614
na
145.74M
$ 0.88
$ 40.07
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2025 06-30-2025 10-Q
2 04-28-2025 03-31-2025 10-Q
3 02-18-2025 12-31-2024 10-K
4 11-04-2024 09-30-2024 10-Q
5 08-05-2024 06-30-2024 10-Q
6 04-29-2024 03-31-2024 10-Q
7 02-20-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-07-2023 06-30-2023 10-Q
10 05-01-2023 03-31-2023 10-Q
11 02-21-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-03-2022 06-30-2022 10-Q
14 05-02-2022 03-31-2022 10-Q
15 02-23-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-26-2021 12-31-2020 10-K
20 11-03-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 03-02-2020 12-31-2019 10-K
24 11-08-2019 09-30-2019 10-Q
25 08-02-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 03-01-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-06-2018 06-30-2018 10-Q
30 05-04-2018 03-31-2018 10-Q
31 03-16-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 update-medifast-q2-eps-022-beats-022-estimate-sales-105600m-beat-96100m-estimate

Medifast (NYSE:MED) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $(0.22) by 200 ...

 medifast-q3-expected-to-be-more-than-060-vs-030-est-sees-q3-sales-70000m-90000m-vs-93800m-est

Medifast (NYSE:MED) Q3 expected to be more than $(0.60) vs $(0.30) Est. sees Q3 sales of $70.000 million-$90.000 million vs $9...

 medifast-q2--expected-to-be-more-than-055-vs-008-est-sees-q2-sales-85000m-105000m-vs-11120m-est

Medifast (NYSE:MED) Q2 expected to be more than $(0.55) vs $(0.08) Est. sees Q2 sales of $85.000 million-$105.000 million vs $...

 medifast-q1-eps-007-beats-027-estimate-sales-11573m-beat-11010m-estimate

Medifast (NYSE:MED) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.27) by 74.0...

 da-davidson-maintains-neutral-on-medifast-lowers-price-target-to-165

DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and lowers the price target from $17 to...

 trump-calls-for-more-tariffs-federal-reserve-minutes-on-deck-whats-driving-markets-wednesday

All three major U.S. indices are red in Wednesday's midday trading as investors weighed President Donald Trump's propos...

 medifast-q1--expected-to-be--0-to-050-vs-019-est-sees-q1-sales-100000m-120000m-vs-13075m-est

Medifast (NYSE:MED) Q1 expected to be more than $(0.50) vs $(0.19) Est. sees Q1 sales of $100.000 million-$120.000 million vs ...

 medifast-q4-adj-010-beats-016-estimate-sales-11900m-beat-11425m-estimate

Medifast (NYSE:MED) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(0.16) by 162....

 medifast-announces-optavia-ascend-high-protein-fiber-rich-mini-meals-and-daily-nutrient-packs-aimed-at-maintaining-lean-muscle-mass-for-glp-1-medication-users-and-weight-management-support

Two new programs incorporate OPTAVIA ASCEND products for easy nutrition, with or without medications, and provide strategies &a...

 da-davidson-upgrades-medifast-to-neutral-raises-price-target-to-17

DA Davidson analyst Linda Bolton Weiser upgrades Medifast (NYSE:MED) from Underperform to Neutral and raises the price targe...

 medifast-sees-q4-gaap-eps-010-065-vs-018-est-sees-sales-100000m-120000m-vs-12995m-est

Medifast (NYSE:MED) is looking for Q4 GAAP EPS of $0.10-0.65 vs $(0.18) analyst estimate. sees sales of $100.000 million-120.00...

 medifast-q3-2024-adj-eps-035-beats-028-estimate-sales-140163m-beat-134150m-estimate

Medifast (NYSE:MED) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $(0.28) by 225 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION